ReviewOncoTargets and therapy2016

Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection.

Steven S Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.